- Home
- SLQT vs TSHA Comparison
SLQT vs TSHA Comparison
Compare SLQT & TSHA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SLQT
- TSHA
- Stock Information
- Founded
- SLQT 1999
- TSHA 2019
- Country
- SLQT United States
- TSHA United States
- Employees
- SLQT N/A
- TSHA N/A
- Industry
- SLQT Specialty Insurers
- TSHA Biotechnology: Pharmaceutical Preparations
- Sector
- SLQT Finance
- TSHA Health Care
- Exchange
- SLQT Nasdaq
- TSHA Nasdaq
- Market Cap
- SLQT 408.2M
- TSHA 403.7M
- IPO Year
- SLQT 2020
- TSHA 2020
- Fundamental
- Price
- SLQT $2.45
- TSHA $2.06
- Analyst Decision
- SLQT Hold
- TSHA Strong Buy
- Analyst Count
- SLQT 1
- TSHA 8
- Target Price
- SLQT $4.00
- TSHA $6.63
- AVG Volume (30 Days)
- SLQT 1.2M
- TSHA 6.0M
- Earning Date
- SLQT 11-04-2024
- TSHA 11-13-2024
- Dividend Yield
- SLQT N/A
- TSHA N/A
- EPS Growth
- SLQT N/A
- TSHA N/A
- EPS
- SLQT N/A
- TSHA N/A
- Revenue
- SLQT $1,381,309,000.00
- TSHA $9,915,000.00
- Revenue This Year
- SLQT $11.29
- TSHA N/A
- Revenue Next Year
- SLQT $14.41
- TSHA N/A
- P/E Ratio
- SLQT N/A
- TSHA N/A
- Revenue Growth
- SLQT 28.72
- TSHA N/A
- 52 Week Low
- SLQT $1.03
- TSHA $1.19
- 52 Week High
- SLQT $4.46
- TSHA $4.32
- Technical
- Relative Strength Index (RSI)
- SLQT 59.54
- TSHA 55.32
- Support Level
- SLQT $1.92
- TSHA $1.19
- Resistance Level
- SLQT $2.65
- TSHA $2.63
- Average True Range (ATR)
- SLQT 0.16
- TSHA 0.24
- MACD
- SLQT 0.06
- TSHA 0.08
- Stochastic Oscillator
- SLQT 72.60
- TSHA 60.42
About SLQT SelectQuote Inc.
SelectQuote Inc is a Direct-to-consumer (DTC) distribution platform which facilitates consumers to shop for health, life and auto & home insurance policies online. The company generates its revenues by selling insurance products on behalf of the insurance carrier partners in the form of a commission. It has four reportable segments namely Senior, Healthcare Services, Life, and Auto & Home. It functions through three lines namely, SelectQuote Senior, SelectQuote Life, and SelectQuote Auto & Home.
About TSHA Taysha Gene Therapies Inc.
Taysha Gene Therapies Inc is a patient-centric gene therapy company to eradicate monogenic CNS disease. It is focused on developing and commercializing AAV-based gene therapies for the treatment of monogenic diseases of the CNS in both rare and large patient populations. The company develops and commercializes transformative gene therapy treatments. Its product pipeline includes TSHA-102 which is a is a self-complementary intrathecally delivered AAV9 gene transfer therapy in clinical evaluation for Rett syndrome.